Lunai Bioworks Inc. (LNAI): Nasdaq/NYSE listing notice — Lunai Bioworks gets additional Nasdaq delisting notice for MVLS; completes $20M merger

Lunai Bioworks Inc.

Received Nasdaq staff determination on April 28, 2026 for non-compliance with $35M market value of listed securities (MVLS) rule.
Completed merger on May 1, 2026, issuing $20M Series B Preferred Stock to support compliance with equity rule.
Stockholders on May 8, 2026 approved reverse stock split authorization (1:3 to 1:30) to address bid price rule.
Company requests extension from Nasdaq Hearings Panel for bid price compliance; prior exception expires June 1, 2026.
Panel previously granted continued listing exception through May 1 (equity) and June 1 (bid price) subject to conditions.

item 3.01 item 5.07

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5550(b)(2)

Exact text from the filing

April 28, 2026 of an additional staff determination letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC regarding compliance with Nasdaq Listing Rule 5550(b)(2). The soliciting material and related disclosures included in the Original Report under the captions “The Special Meeting and the Proposals Being Voted On,” “Additional Information and Where to Find It” and “Participants in the Solicitation,” are no longer applicable because the Special Meeting has been held and the proposals submitted to a vote of stockholders thereat have been acted upon. Except as expressly se

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR

accession 0001731122-26-000705

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.